Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

"WASTES to WINGS - Constructing a High-Throughput Sustainable Aviation Fuel (SAF) Research Platform to Facilitate Zero Carbon Air Travel in Hong Kong". The projects reflect the importance of ...

Supported by clinical research, GetSimpli is a promising option for anyone looking to enhance their health without the hassle of injections. The effectiveness of GetSimpli Oral Tirzepatide is ...

SAF initiative with F-35s is expected to guide ongoing sustainable solutions in the defence sector. Credit: Credit: Joris van Boven/Shutterstock. The Norwegian Air Force has taken a pioneering step by ...

Mounjaro is the brand name for tirzepatide, and research shows that people with overweight and obesity have lost up to 25% of their body weight on this medication. Social media users have latched onto ...

Jet Aviation will provide sustainable aviation fuel (SAF) to aircraft attending the World Economic Forum in Davos, Switzerland, from January 20 to 24, 2025. The news comes days after the company ...

Meet the good folks at Metafuels, who are working furiously at Switzerland's largest research hub for natural ... The "e" prefix is premised on a SAF manufacturing process that uses renewable ...

Research conducted at the Illinois Sustainable Technology Center (ISTC) in that state could help overcome what has been cited as a challenge in the adoption of sustainable aviation fuels (SAF) in ...

Although tirzepatide use was associated with elevated amylase and lipase levels, risk for pancreatitis was not elevated among users of tirzepatide vs placebo. Tirzepatide does not yield a significant ...

The report highlights: Projected growth: Domestic projects could achieve over 3 billion gallons of annual SAF production by 2030, surpassing the initial target. Investment boom: Announced ...

The injected Zepbound® produced a total of 38 adverse events across the study group of 9 persons, whereas the oral DehydraTECH-tirzepatide only produced 20 adverse events, a reduction of 47%.